Publications
Original Article
A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer
Clinical Trials
2023
Authors:
Disis ML, Dang Y, Coveler AL, Childs JS, Higgins DM, Liu Y, Zhou J, Mackay S, Salazar LG
Journal:
Clinical Cancer Research
Volume:
29(17)
Page:
3362-3371
Pubmed:
Original Article
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer
Antigen Discovery & Vaccines
2022
Authors:
Cecil, D.L., Curtis, B, Gad, E., Gormley, M, Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A., and Disis, M.L.
Journal:
Scientific Reports
Volume:
12
Page:
13618
Pubmed:
Original Article
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes
Antigen Discovery & Vaccines
2022
Authors:
Cecil DL, Gad EA, Corulli LR, Drovetto N, Lubet RA, Disis ML
Journal:
Cancer Prevention Research
Volume:
15(4)
Page:
225-231
Pubmed:
Original Article
Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon Cancer
Antigen Discovery & Vaccines
2022
Authors:
Waggie, KS, Corulli, LR, Cecil, D, Rodmaker, ER, Walsh, C, and Disis, ML
Journal:
Comparative Medicine
Volume:
72(5)
Page:
330-335
Pubmed:
Original Article
Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer
Clinical Trials
2022
Authors:
Disis, ML, Guthrie, KA, Liu, Y, Coveler, AL, Higgins, DM, Childs, JS, Dang, Y, and Salazar, LG
Journal:
JAMA Oncology
Volume:
9(1)
Page:
71-78
Pubmed:
Original Article
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
2021
Authors:
Stanton, SE, Gad E, Ramos, E, Corulli LR, Annis, J, Katayama, H, Hamash S and Disis, ML
Journal:
Nature Partner Journals Breast Cancer
Volume:
7(1)
Page:
50
Pubmed:
Original Article
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Clinical Trials
2021
Authors:
John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Doreen M Higgins, Jennifer S Childs, Hania N Shakalia, Ron E Swensen, Sasha E Stanton, Anna V Tinker, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Mary L Disis, Barbara A Goff
Journal:
Journal for ImmunoTherapy of Cancer
Volume:
9(9)
Page:
Pubmed:
Original Article
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
Antigen Discovery & Vaccines
2021
Authors:
Corulli LR, Cecil DL, Gad E, Koehnlein M, Coveler AL, Childs JS, Lubet RA, Disis ML.
Journal:
Frontiers in Immunology
Volume:
12
Page:
Pubmed:
Original Article
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
T Cell Function & Therapy
2021
Authors:
Schroeder BA, LaFranzo NA, LaFleur BJ, Gittelman RM, Vignali M, Zhang S, Flanagan KC, Rytlewski J, Riolobos L, Schulte BC, Kim TS, Chen E, Smythe KS, Wagner MJ, Mantilla JG, Campbell JS, Pierce RH, Jones RL, Cranmer LD, Pollack SM
Journal:
Journal for ImmunoTherapy of Cancer
Volume:
9(8)
Page:
Pubmed:
Original Article
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways
Antigen Discovery & Vaccines
2021
Authors:
Cecil, D., Park, K H, Curtis, B, Corulli, L, and Disis, ML
Journal:
Journal for Immunotherapy of Cancer
Volume:
9
Page:
Pubmed: